FDA cleared the ECHELON Synergy from Fujifilm Corporation on Oct 9, 2026 under K262902, a traditional 510(k). The device falls under product code LNH, System, Nuclear Magnetic Resonance Imaging, regulated at 21 CFR 892.1000 as a Class 2 device. The review panel was Radiology.
FDA logged the submission as received on Aug 18, 2026. The decision came 52 days later, inside the 90 FDA-day goal for a 510(k).
Fujifilm Corporation has 8 other decisions in the tracker over the last 12 months: K261229 (SCENARIA View Phase 6.0), K261283 (APERTO Lucent MRI System), K253836 (FCT iStream Phase 2), K261170 (BA-004CC).